Votes & Verdicts
By Bloomberg
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Bloomberg
Category: Investing
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 46
Description
Votes and Verdicts is a series that examines the intersection of business, policy and law. It features conversations between Bloomberg Intelligence's team of litigation and policy analysts and thought leaders discussing legal and policy issues affecting markets and business decisions across many sectors.
| Episode | Date |
|---|---|
|
Medicare’s Hospital-at-Home and Other Reforms
|
May 17, 2024 |
|
Is TikTok on the Countdown to a Shutdown?
|
May 09, 2024 |
|
Google, LiveNation, Uber and Other Catalysts
|
May 03, 2024 |
|
Kelleher on FinReg, ‘Kangaroo’ Courts
|
Apr 18, 2024 |
|
Pharma and Biotech Drug Pricing Policy Outlook
|
Apr 11, 2024 |
|
Antitrust Enforcers’ New Merger Guidelines
|
Mar 21, 2024 |
|
Eugene Scalia on Beating Regulators in Court
|
Mar 12, 2024 |
|
Market and Reimbursement Outlook for Cell and Gene Therapies
|
Mar 07, 2024 |
|
3M, Synopsys, Capital One & Other Catalysts
|
Mar 01, 2024 |
|
Can Legal State Pot Put US Law Up in Smoke?
|
Feb 27, 2024 |
|
Biden’s Lab-Developed Test Proposal
|
Feb 20, 2024 |
|
Biden’s Drug-Pricing Expansion Plan, Part 2
|
Feb 13, 2024 |
|
Apple, Bayer, Moderna and Other Catalysts
|
Feb 02, 2024 |
|
Apple’s Antitrust App-Store Battle With Epic
|
Jan 25, 2024 |
|
Washington’s Crowded Outlook for 2024
|
Jan 23, 2024 |
|
Biden’s Drug Pricing March-in Proposal
|
Jan 18, 2024 |
|
Meta’s Biggest Legal, Regulatory Questions
|
Dec 18, 2023 |
|
Antitrust Changes Could Hinder M&A
|
Dec 11, 2023 |
|
Apple, Disney, Novo Nordisk, Other Catalysts
|
Dec 01, 2023 |
|
J&J, 3M's Chap 11 Play in Talc, Earplug Mass Torts
|
Nov 14, 2023 |
|
Berkshire, Google, Pega & Other Catalysts
|
Nov 03, 2023 |
|
Consumer Finance Impact of a CFPB Run Amok
|
Oct 31, 2023 |
|
Will IRA Drug Pricing Raise Employer Costs?
|
Oct 17, 2023 |
|
JJCI, Bayer, GSK, Mass Tort Litigation Risks
|
Oct 09, 2023 |
|
Bausch, GBTC, Merck, Meta & Other Catalysts
|
Sep 29, 2023 |
|
AI’s Biggest Legal and Regulatory Questions
|
Sep 26, 2023 |
|
FTC BioPharma M&A Approach Clashes With Sector
|
Sep 21, 2023 |
|
Likelihood Medicare Will Cover Obesity Drugs
|
Sep 05, 2023 |
|
3M, Drug Pricing, Google and Other Catalysts
|
Aug 30, 2023 |
|
Can Anyone Defeat Trump? Insights on the Forthcoming GOP Debates
|
Aug 17, 2023 |
|
3M, Google, Bank Rules, Other 2H Catalysts
|
Jul 21, 2023 |
|
Craig Burton on Inflation Reduction Act
|
Jul 19, 2023 |
|
Why PFAS Legal Risks Persist for 3M, Peers
|
Jul 13, 2023 |
|
Why a TikTok Ban Faces a Major Legal Hurdle
|
Jun 06, 2023 |
|
Catalysts to Watch – AI Laws, PFAS Trial
|
Jun 02, 2023 |
|
Adamantine’s Bays on Sustainable Investing
|
May 31, 2023 |
|
Margaux Hall on Drug Pricing Negotiation
|
May 24, 2023 |
|
Bill Hoagland on Debt-Ceiling Negotiations
|
May 15, 2023 |
|
Daniel Horwitz on Trump Indictment Strengths
|
May 15, 2023 |
|
Gottlieb on the Future of Crypto Policy, Law
|
May 15, 2023 |
|
The PFAS Problem, Regulatory and Other Issues
|
May 15, 2023 |
|
Crisis of Confidence, Regional Banks’ Future
|
May 15, 2023 |
|
The FTC’s Evolving Approach to Assessing M&A
|
May 15, 2023 |
|
The Biggest Tech-Regulation Questions
|
May 15, 2023 |
|
Energy's DC Opportunity, Risk with Schneider
|
May 15, 2023 |
|
Mulvaney on Crypto, the CFPB, and More
|
May 09, 2023 |